4//SEC Filing
Mohindru Mani 4
Accession 0001209191-19-019712
CIK 0001346830other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:42 PM ET
Size
9.1 KB
Accession
0001209191-19-019712
Insider Transaction Report
Form 4
Mohindru Mani
CFO & Chief Strategy Officer
Transactions
- Exercise/Conversion
Common Stock
2019-03-13$14.06/sh+16,041$225,536→ 24,067 total - Sale
Common Stock
2019-03-13$19.12/sh−16,041$306,704→ 8,026 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-03-13−16,041→ 336,875 totalExercise: $14.06Exp: 2027-08-15→ Common Stock (16,041 underlying)
Footnotes (2)
- [F1]This exercise and corresponding sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 7, 2018.
- [F2]One-fourth (1/4th) of the 385,000 shares subject to this option vested and became exercisable on August 15, 2018; the balance of the shares shall vest and become exercisable in a series of 36 successive equal monthly installments measured from August 15, 2018, subject to the reporting person's continuous service with the issuer as of each such date.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001664708
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 4:42 PM ET
- Size
- 9.1 KB